MedPath

PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma

Recruiting
Conditions
Pancreas Cancer
Pancreas Adenocarcinoma
Registration Number
NCT04099134
Lead Sponsor
University of Ulm
Brief Summary

PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
5000
Inclusion Criteria
  • Treatment naive histologically or cytologically proven pancreatic ductal adenocarcinoma (PDAC) or highly suspicious diagnosis (only pre-curative-intended resection)
  • Age =>18 years
  • written informed consent
Exclusion Criteria
  • papillary cancer
  • neuroendocrine pancreatic tumors

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
General assessment of applied therapy modalities in pancreatic cancerFirst diagnose to death or end of surveillance (5 years after curative resection)
Quality of life in pancreatic cancer patientsFirst diagnose to death or end of surveillance (5 years after curative resection)

EORTC QLQ c30 and PAN 26

Secondary Outcome Measures
NameTimeMethod
Assessment of tumor surveillance in pancreatic cancer patientsFirst diagnose to death or end of surveillance (5 years after curative resection)
General epidemiologic assessmentFirst diagnose to death or end of surveillance (5 years after curative resection)

Epidemiologic questionaire

Evaluation of predictive and prognostic markersFirst diagnose to death or end of surveillance (5 years after curative resection)

Trial Locations

Locations (1)

Universitätsklinikum Ulm

🇩🇪

Ulm, Germany

© Copyright 2025. All Rights Reserved by MedPath